Guiyang Xintian Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 745.26 million compared to CNY 541.86 million a year ago. Revenue was CNY 745.26 million compared to CNY 541.86 million a year ago.

Net income was CNY 88.93 million compared to CNY 61.06 million a year ago. Basic earnings per share from continuing operations was CNY 0.5519 compared to CNY 0.3795 a year ago. Diluted earnings per share from continuing operations was CNY 0.5113 compared to CNY 0.3536 a year ago.